Therapeutic Application of rTMS in Atypical Parkinsonian Disorders.
Journal
Behavioural neurology
ISSN: 1875-8584
Titre abrégé: Behav Neurol
Pays: Netherlands
ID NLM: 8914585
Informations de publication
Date de publication:
2021
2021
Historique:
received:
30
04
2021
accepted:
03
12
2021
entrez:
3
1
2022
pubmed:
4
1
2022
medline:
5
1
2022
Statut:
epublish
Résumé
The terms atypical parkinsonian disorders (APDs) and Parkinson plus syndromes are mainly used to describe the four major entities of sporadic neuronal multisystem degeneration: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and dementia with Lewy bodies (LBD). APDs are characterized by a variety of symptoms and a lack of disease modifying therapies; their treatment thus remains mainly symptomatic. Brain stimulation via repetitive transcranial magnetic stimulation (rTMS) is a safe and noninvasive intervention using a magnetic coil, and it is considered an alternative therapy in various neuropsychiatric pathologies. In this paper, we review the available studies that investigate the efficacy of rTMS in the treatment of these APDs and Parkinson plus syndromes.
Identifiants
pubmed: 34976231
doi: 10.1155/2021/3419907
pmc: PMC8718319
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3419907Informations de copyright
Copyright © 2021 Chrysi Petsani et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):464-7
pubmed: 16543523
Neuron. 2016 Jun 1;90(5):941-7
pubmed: 27210553
Depress Anxiety. 2000;12(3):124-9
pubmed: 11126186
J Physiol. 2000 Mar 1;523 Pt 2:503-13
pubmed: 10699092
Clin Neurophysiol. 2009 Dec;120(12):2008-2039
pubmed: 19833552
J Clin Neurol. 2016 Jan;12(1):57-64
pubmed: 26365021
Neuropsychologia. 1999 May;37(5):537-44
pubmed: 10340313
Neurotherapeutics. 2010 Apr;7(2):204-12
pubmed: 20430320
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Mov Disord. 2011 May;26(6):1083-95
pubmed: 21626553
Neuromodulation. 2018 Jun;21(4):402-408
pubmed: 28266761
Clin Neurophysiol. 2004 Aug;115(8):1786-95
pubmed: 15261857
Psychogeriatrics. 2009 Jun;9(2):56-61
pubmed: 19604326
Brain Stimul. 2010 Apr;3(2):95-118
pubmed: 20633438
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Neuropsychologia. 2019 Apr;127:148-157
pubmed: 30836131
Nervenarzt. 2018 Oct;89(10):1083-1094
pubmed: 30120488
Curr Treat Options Neurol. 2014 Mar;16(3):282
pubmed: 24469408
Mov Disord. 2013 Mar;28(3):362-9
pubmed: 23325625
CNS Drugs. 2016 Jul;30(7):629-36
pubmed: 27222018
Brain Connect. 2015 Sep;5(7):451-9
pubmed: 25786196
J Neurol Neurosurg Psychiatry. 1996 Jun;60(6):615-20
pubmed: 8648326
Mov Disord. 2007 Mar 15;22(4):490-7
pubmed: 17260333
Clin Neurophysiol. 2004 Nov;115(11):2530-41
pubmed: 15465443
Brain. 2010 Jun;133(Pt 6):1578-90
pubmed: 20472654
Clin Neurophysiol. 2020 Feb;131(2):474-528
pubmed: 31901449
J Auton Nerv Syst. 1998 Dec 11;74(2-3):189-92
pubmed: 9915636
Mov Disord. 2010 Oct 30;25(14):2413-9
pubmed: 20818672
Parkinsonism Relat Disord. 2015 Sep;21(9):1113-4
pubmed: 26182830
Parkinsonism Relat Disord. 2014 Jun;20(6):632-6
pubmed: 24698055
Neurology. 1997 Jan;48(1):119-25
pubmed: 9008506
Neurol Sci. 2015 Sep;36(9):1651-7
pubmed: 25917399
Front Behav Neurosci. 2018 May 09;12:90
pubmed: 29867391
Med Hypotheses. 2010 May;74(5):877-9
pubmed: 20006914
Behav Neurol. 2018 Jan 18;2018:8584653
pubmed: 29568339
Mov Disord. 2014 Dec;29(14):1758-66
pubmed: 25370486
Nat Rev Neurol. 2017 Apr;13(4):232-243
pubmed: 28303913
Curr Opin Neurol. 2007 Aug;20(4):434-7
pubmed: 17620879
Mov Disord. 1997 Mar;12(2):133-47
pubmed: 9087971
Neuron. 2007 Jul 19;55(2):187-99
pubmed: 17640522
Brain Stimul. 2019 Nov - Dec;12(6):1588-1591
pubmed: 31378601
Lancet Neurol. 2012 Apr;11(4):361-8
pubmed: 22441197
J Alzheimers Dis. 2015;48(1):251-60
pubmed: 26401945
Healthcare (Basel). 2021 Jul 28;9(8):
pubmed: 34442086
Cerebellum. 2021 Aug;20(4):662-666
pubmed: 33544370
J Physiol. 2008 Jan 15;586(2):325-51
pubmed: 17974592
Int Psychogeriatr. 2018 Mar;30(3):395-407
pubmed: 28988547
Ann Transl Med. 2016 Mar;4(6):103
pubmed: 27127756
Curr Opin Neurol. 2010 Aug;23(4):394-400
pubmed: 20610990
Dtsch Arztebl Int. 2016 Feb 5;113(5):61-9
pubmed: 26900156
Brain Stimul. 2014 Jan-Feb;7(1):29-35
pubmed: 23928103
Epilepsy Behav. 2007 Jun;10(4):521-8
pubmed: 17493877
Brain Topogr. 2010 Jan;22(4):294-306
pubmed: 19288184
Brain Res. 1999 Jan 16;816(1):78-83
pubmed: 9878693
Gut. 2017 Jun;66(6):1031-1038
pubmed: 27053630
Acta Neurol Belg. 2009 Sep;109(3):200-4
pubmed: 19902813
J Exp Neurosci. 2015 Jun 03;9:43-51
pubmed: 26064066
Cerebellum. 2014 Feb;13(1):121-38
pubmed: 23943521
Lancet. 1985 May 11;1(8437):1106-7
pubmed: 2860322
Front Microbiol. 2018 Aug 24;9:1991
pubmed: 30197636
Ann Phys Rehabil Med. 2015 Sep;58(4):208-213
pubmed: 26319963